Understanding Numbness in Multiple Sclerosis

Numbness is one of the most common and often the first symptoms experienced by people with multiple sclerosis (MS). For those living with MS, the sensation can be confusing, distressing, and sometimes even painful. But what exactly is numbness, why does it happen in MS, and what can be done to manage it?

What Is Numbness?

In simple terms, numbness is a loss or change of sensation. It can feel like a part of the body is “asleep,” as though it has been injected with a local anesthetic, or as if there’s a thick glove or sock covering it. Some people describe it as tingling, pins and needles, or a feeling of pressure. Others say it feels cold, rubbery, or oddly heavy.

Interestingly, numbness isn’t always the complete absence of feeling. Many MS patients report that the numbness is accompanied by uncomfortable or even painful sensations—a phenomenon known as dysesthesia. In such cases, a light touch may feel like burning or electric shocks, and even clothing brushing against the skin can become irritating or painful (National Multiple Sclerosis Society, n.d.).

What Causes Numbness in MS?

To understand numbness in MS, it helps to know a little about how the nervous system works. Sensory information, such as temperature, pressure, and pain is carried from the body to the brain through a network of nerves. These nerves are insulated by a fatty substance called myelin, which allows electrical signals to travel quickly and accurately.

In MS, the immune system mistakenly attacks and damages this myelin, leading to inflammation and scar tissue (called lesions) in the brain and spinal cord. These lesions disrupt the transmission of sensory signals, also known as nerve dagame, causing symptoms like numbness, tingling, or altered sensations (Compston & Coles, 2008).

Where numbness occurs depends on where the lesions form. Lesions in the spinal cord (cervical or thoracic region) can cause numbness in the limbs or torso, while brainstem or cortical lesions may affect the face or one side of the body. Numbness may affect a small patch or a large region, and it may come and go or persist over time.

Is Numbness Acute or Chronic?

Numbness in MS can be either an acute or chronic symptom. It is often one of the first signs of a relapse, an episode of new or worsening symptoms caused by active inflammation, or associated with illness, such as urinary tract infection, upper respiratory infection, and fevers. During a relapse, numbness may develop suddenly and persist for days or weeks before slowly improving as the inflammation resolves (Lublin et al., 2014).

However, numbness can also become a long-term or residual symptom. When nerve damage is significant or if the body fails to fully repair the affected myelin, numbness may linger between relapses. Chronic numbness can fluctuate in intensity, sometimes worsening with fatigue, heat, or stress—a phenomenon known as a pseudo-relapse (Frohman et al., 2005).

While numbness itself is not typically dangerous, it can increase the risk of injury. For example, someone with numb fingers may not feel a cut or burn, and someone with numb feet may not notice a developing blister. For this reason, regular skin checks and other protective strategies are important.

Treatment Options for Numbness

While numbness in MS can’t always be fully reversed, there are treatment options to reduce its severity or manage its impact on daily life.

1. Corticosteroids for Relapses

If numbness is part of a relapse, high-dose corticosteroids such as intravenous or oral methylprednisolone may be prescribed to reduce inflammation and accelerate recovery.

These drugs are effective at shortening the duration of a relapse, though they don’t alter the long-term course of MS (Sellebjerg et al., 1998).

2. Medications for Painful Sensations

If numbness is associated with pain or discomfort, medications used for neuropathic pain—such as Neurontin (gabapentin), Lyrica (pregabalin), amitriptyline, or Cymbalta (duloxetine), may offer relief. These drugs help calm overactive nerve signaling but don’t restore normal sensation (O’Connor et al., 2008).

3. Rehabilitation and Therapy

Physical and occupational therapy can be very helpful in managing numbness. Therapists can teach techniques to improve coordination and adapt to sensory changes. This might include balance training, strengthening exercises, and using assistive devices to maintain independence and reduce fall risk (Hebert et al., 2011).

4. Self-Care Strategies

While not a cure, lifestyle changes and home-based strategies can improve comfort and safety:

• Protect numb areas from burns, cuts, and pressure injuries.
• Avoid heat exposure, which can temporarily worsen symptoms.
• Manage fatigue and stress, both of which may intensify sensory symptoms.
• Practice mindfulness or relaxation, which some people find helpful in reducing sensory discomfort.

Living with Numbness

Numbness can affect everyday activities such as gripping objects, typing, or walking. But with knowledge and support, people with MS can adapt and thrive.

It’s important to communicate with your healthcare team about changes in numbness, especially if it interferes with daily life or worsens suddenly. While there is no single solution, a personalized approach that includes medication, rehabilitation, and self-care can make a significant difference.

Final Thoughts

Numbness may not be visible to others, but its impact on people living with MS is real. Understanding how and why it happens is the first step in managing it. Whether it’s an early symptom or a long-term one, numbness doesn’t have to define your MS journey. With medical support, smart strategies, and resilience, you can maintain quality of life and stay engaged in the things that matter most.

References

Compston, A., & Coles, A. (2008). Multiple sclerosis. The Lancet, 372(9648), 1502–1517. https://doi.org/10.1016/S0140–6736(08)61620–7

Frohman, E. M., Soldan, S. S., & McFarland, H. F. (2005). Pseudoexacerbations in multiple sclerosis. The Lancet Neurology, 4(10), 613–625. https://doi.org/10.1016/S14744422(05)70171–1

Hebert, J. R., Corboy, J. R., Manago, M. M., & Schenkman, M. (2011). Effects of vestibular rehabilitation on multiple sclerosis–related fatigue and upright postural control: A randomized controlled trial. Neurology Research International, 2011, 1–9. https://doi.org/10.1155/2011/219469

Lublin, F. D., Reingold, S. C., Cohen, J. A., Cutter, G. R., Sørensen, P. S., Thompson, A. J., … & Polman, C. H. (2014). Defining the clinical course of multiple sclerosis: The 2013 revisions. Neurology, 83(3), 278–286. https://doi.org/10.1212/WNL.0000000000000560

National Multiple Sclerosis Society. (n.d.). Numbness and tingling.
https://www.nationalmssociety.org/Symptoms–Diagnosis/MS–Symptoms/Numbness

O’Connor, A. B., Schwid, S. R., Herrmann, D. N., Markman, J. D., & Dworkin, R. H. (2008).

Pain associated with multiple sclerosis: Systematic review and proposed classification. Pain, 137(1), 96–111. https://doi.org/10.1016/j.pain.2007.08.024

Sellebjerg, F., Frederiksen, J. L., Nielsen, P. M., Olesen, J., & Frederiksen, J. L. (1998). Double-blind, randomized, placebo-controlled study of methylprednisolone in acute optic neuritis. Neurology, 51(5 Suppl 5), S25–S28. https://doi.org/10.1212/WNL.51.5_Suppl_5.S25